• AO/PI Double Staining Kit: Practical Cell Viability Guide

  2026-08-27

  The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for distinguishing viable, apoptotic, and necrotic cell populations in one sample. It is suitable for cell viability screening and comparative experiments, but it should not be treated as a standalone confirmation of a specific cell-death pathway or used without sample- and instrument-specific validation.

• Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5

  2026-08-27

  A practical, scenario-based guide to using Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 (SKU K1188) for acid mucin detection, chondrogenic differentiation, and morphology assessment. It explains assay compatibility, workflow controls, interpretation limits, storage, and vendor-selection considerations for research laboratories.

• Romidepsin (FK228) in HCC Splicing Research

  2026-08-26

  Romidepsin (FK228) offers a practical way to connect class I HDAC inhibition with chromatin state, SmD2 regulation, alternative splicing, and PARP-inhibitor response. This workflow translates the reference study into dose-response, acetylation, splice-junction, and combination assays while separating established evidence from pilot optimization.

• Merbromin as a Mixed-Type Inhibitor of SARS-CoV-2 3CLpro

  2026-08-26

  The reference study used an enzymatic high-throughput screen of approximately 6,000 compounds to identify Merbromin as a selective inhibitor of the SARS-CoV-2 3CLpro protease. Kinetic, binding, and docking analyses support a mixed-type inhibition model involving two putative binding sites, while comparison with Proteinase K, trypsin, and papain indicates meaningful protease selectivity.

• Novobiocin Susceptibility in Canine Staphylococci

  2026-08-25

  This study compared in vitro susceptibility to novobiocin and mupirocin among meticillin-susceptible and meticillin-resistant staphylococci from healthy dogs and dogs with superficial pyoderma. Its main contribution is a clinically relevant isolate-level comparison showing strong novobiocin activity against most susceptible isolates, but substantially more variable activity against resistant populations.

• WZ4003 Lowers Tau p-Ser356 in Brain Tissue

  2026-08-25

  Taylor et al. characterized tau phosphorylation at Ser356 as an Alzheimer’s disease-associated pathology and tested the NUAK1/2 inhibitor WZ4003 in mouse and human brain slice cultures. The study’s most important translational insight is that NUAK inhibition lowered p-tau Ser356 in human tissue, while mouse slices showed broader changes in tau and neuronal proteins that require careful interpretation.

• Proteinase K as a Protease Mapping Tool

  2026-08-24

  Proteinase K is more than a DNA-cleanup reagent: it can serve as a controlled protease probe for distinguishing extracellular-vesicle surface proteins from protected cargo. This article connects Proteinase K chemistry with recent Candida albicans EV research and shows how to design interpretable mechanistic assays.

• SW033291: 15-PGDH Inhibitor Workflow

  2026-08-24

  SW033291 is a potent 15-PGDH inhibitor for connecting enzyme blockade with prostaglandin E2 elevation, hematopoietic stem cell expansion, and tissue repair readouts. This practical workflow separates biochemical potency from cell and marrow phenotypes while clarifying how recent muscle-regeneration findings can guide, but not replace, SW033291-specific validation.

• Vancomycin Hydrochloride as a Resistance Benchmark

  2026-08-23

  Vancomycin hydrochloride is more than a familiar antimicrobial reagent: it is a mechanistically defined benchmark for Gram-positive bacteria inhibition, bacterial susceptibility testing, and antibiotic resistance assay design. This article connects its D-alanyl-D-alanine targeting mechanism with time-resolved resistance analysis, translational infection models, and the semi-mechanistic PKPD framework used to dissect ceftolozane/tazobactam resistance in Pseudomonas aeruginosa.

• Spatial Proteomics Maps PD-L1–IL-6 Crosstalk in PSC

  2026-08-22

  A recent JHEP Reports study integrates spatial proteomics with cell-cell cross-talk analysis to identify a spatially organized relationship between PD-L1 and IL-6 signaling in human primary sclerosing cholangitis. The work links immune-checkpoint biology with cytokine activity at the biliary epithelial–immune interface and provides a rationale for mechanism-focused follow-up studies.

• 5-Methyl-CTP for Translational mRNA Design

  2026-08-22

  5-Methyl-CTP enables controlled incorporation of methylated cytidine during mRNA synthesis with modified nucleotides. This article connects transcript chemistry to delivery, antigen presentation, and practical assay design for mRNA drug development.

• MTT Workflow for Mitochondrial Rescue Studies

  2026-08-21

  Learn how to use MTT to quantify cardiomyocyte metabolic recovery, compare sequential treatment schedules, and troubleshoot assay artifacts after ischemia-reperfusion modeling. The workflow connects a practical colorimetric endpoint with the sequential mitochondrial transplantation strategy described in recent myocardial injury research.

• CBX2, Interferon Signaling, and Tumor Immunogenicity

  2026-08-20

  The reference study identifies a noncanonical CBX2–RACK1–HDAC1 corepressor complex that represses interferon-stimulated genes and reduces tumor immunogenicity independently of canonical PRC activity. Its results connect CBX2 abundance with an immune-suppressive tumor microenvironment and weaker immunotherapy responses, while suggesting experimental strategies for studying epigenetic control of antitumor immunity.

• Neurotensin: Assay Design for GPCR Trafficking

  2026-08-20

  Neurotensin is a powerful Neurotensin receptor 1 activator for resolving receptor recycling, miR-133α modulation, and assay-specific signal confounding. This guide translates fluorescence-quality principles into a rigorous framework for GPCR trafficking and gastrointestinal cell studies.

• Polyethylenimine Linear: PEI MW 40,000 Workflows

  2026-08-19

  Build reproducible DNA delivery workflows for HEK-293 transfection, transient gene expression, and recombinant protein production with a serum-compatible linear PEI formulation. The article translates a calcium-phosphate optimization study into practical screening, scale-up, and troubleshooting decisions without treating its conditions as a universal PEI protocol.

544 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page